Odonate Therapeutics, Inc. – OTC:ODTC

Odonate Therapeutics stock price today

$1.8
-17098.2
-99.99%
Financial Health
0
1
2
3
4
5
6
7
8
9

Odonate Therapeutics stock price monthly change

+500.11%
month

Odonate Therapeutics stock price quarterly change

+418.18%
quarter

Odonate Therapeutics stock price yearly change

+994086.05%
year

Odonate Therapeutics key metrics

Market Cap
69.28M
Enterprise value
N/A
P/E
-0.67
EV/Sales
N/A
EV/EBITDA
0.21
Price/Sales
N/A
Price/Book
0.95
PEG ratio
-0.12
EPS
15277.97
Revenue
N/A
EBITDA
-17.78M
Income
-2.47M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Odonate Therapeutics stock price history

Odonate Therapeutics stock forecast

Odonate Therapeutics financial statements

Odonate Therapeutics, Inc. (OTC:ODTC): Profit margin
Jun 2021 0 -22.48M
Sep 2021 0 -23.93M
Sep 2022 0 39.19M
Dec 2022 0 4.75M
Odonate Therapeutics, Inc. (OTC:ODTC): Debt to assets
Dec 2020 167886000 31.74M 18.91%
Mar 2021 142879000 37.57M 26.3%
Jun 2021 118573000 33.94M 28.63%
Sep 2021 105773000 34.40M 32.52%
Odonate Therapeutics, Inc. (OTC:ODTC): Cash Flow
Mar 2021 -24.90M -21K 825K
Jun 2021 -23.02M -5K 0
Sep 2021 -15.09M 0 0
Dec 2022 5.47M -37.39M 0

Odonate Therapeutics alternative data

Odonate Therapeutics, Inc. (OTC:ODTC): Employee count
Aug 2023 137
Sep 2023 137
Oct 2023 137
Nov 2023 137
Dec 2023 137
Jan 2024 137
Feb 2024 137
Mar 2024 137
Apr 2024 137
May 2024 137
Jun 2024 137
Jul 2024 137

Odonate Therapeutics other data

14.26% -49.66%
of ODTC is owned by hedge funds
5.40M -18.83M
shares is hold by hedge funds
  • What's the price of Odonate Therapeutics stock today?

    One share of Odonate Therapeutics stock can currently be purchased for approximately $1.8.

  • When is Odonate Therapeutics's next earnings date?

    Unfortunately, Odonate Therapeutics's (ODTC) next earnings date is currently unknown.

  • Does Odonate Therapeutics pay dividends?

    No, Odonate Therapeutics does not pay dividends.

  • How much money does Odonate Therapeutics make?

    Odonate Therapeutics has a market capitalization of 69.28M.

  • What is Odonate Therapeutics's stock symbol?

    Odonate Therapeutics, Inc. is traded on the OTC under the ticker symbol "ODTC".

  • What is Odonate Therapeutics's primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Odonate Therapeutics?

    Shares of Odonate Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Odonate Therapeutics have?

    As Jul 2024, Odonate Therapeutics employs 137 workers.

  • When Odonate Therapeutics went public?

    Odonate Therapeutics, Inc. is publicly traded company for more then 7 years since IPO on 7 Dec 2017.

  • What is Odonate Therapeutics's official website?

    The official website for Odonate Therapeutics is odonate.com.

  • Where are Odonate Therapeutics's headquarters?

    Odonate Therapeutics is headquartered at 3 East 28th Street, New York, NY.

  • How can i contact Odonate Therapeutics?

    Odonate Therapeutics's mailing address is 3 East 28th Street, New York, NY and company can be reached via phone at +33 22060935.

Odonate Therapeutics company profile:

Odonate Therapeutics, Inc.

odonate.com
Exchange:

OTC

Full time employees:

137

Industry:

Shell Companies

Sector:

Financial Services

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

3 East 28th Street
New York, NY 10016

CIK: 0001717452
ISIN: US6760791060
CUSIP: 676079106